JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for CATALYST PHARMACEUTICALS · Pharmaceutical Company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

General FDA issues related to orphan drugs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem